Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06555952 · ClinicalTrials.gov registry record · NA
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
A NA study of Hypertension and Pre Diabetes, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06555952 is a NA study of Hypertension and Pre Diabetes that is actively recruiting participants, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 80 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06555952, a NA study of Hypertension and Pre Diabetes, is actively recruiting participants, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Inflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research will study the effects of taking 150mg of MegaNatural BP GSE per day on blood pressure levels along with influences on heart health through assessing the function of the blood vessel lining and levels of inflammation.
Conditions Studied
Interventions
- OTHER Placebo Capsule
- DIETARY_SUPPLEMENT MegaNatural-BP SR 150Mg Tablet
Study Locations (1)
Illinois
- Clinical Nutrition Research Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-08-08 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06555952
The ClinicalTrials.gov registry entry for NCT06555952 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo Capsule is the first listed.
NCT06555952 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06555952 about?
NCT06555952 is a clinical study titled "MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors". Inflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research will study the effects ...
What is the current status of trial NCT06555952?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-08-08. Estimated completion is 2026-12-31.
What conditions does trial NCT06555952 study?
This clinical trial studies the following conditions: Hypertension, Pre Diabetes.
What interventions are being tested in trial NCT06555952?
The interventions under investigation include: Placebo Capsule (OTHER), MegaNatural-BP SR 150Mg Tablet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06555952?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06555952 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.